Breaking News Bar

Business News and Information

Idera CEO says momentum remains strong despite stock declines

Since becoming the Massachusetts drug developer whose shares rose faster than any other in 2013, Idera Pharmaceuticals has seen some pullback along with the rest of the market so far this year...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear